Israel Englander Sc Pharmaceuticals Inc. Transaction History

Millennium Management LLC

$192 Billion
Q2 2025

A detailed history of Israel Englander (Millennium Management LLC) transactions in Sc Pharmaceuticals Inc. stock. As of the latest transaction made, Millennium Management LLC holds 538,470 shares of SCPH stock, worth $2.58 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

538,470

Previous 84,390 538.07%

Holding current value

$2.58 Million

Previous $221,000 828.05%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$2.02 - $4.27 $917,241 - $1.94 Million	454,080 Added 538.07%	538,470 $2.05 Million
Q1 2025 May 15, 2025	SELL	$2.63 - $3.68 $67,114 - $93,909	-25,519 Reduced 23.22%	84,390 $221,000
Q4 2024 Feb 14, 2025	SELL	$3.14 - $4.53 $98,052 - $141,458	-31,227 Reduced 22.13%	109,909 $389,000
Q3 2024 Nov 14, 2024	BUY	$4.12 - $5.51 $45,591 - $60,973	11,066 Added 8.51%	141,136 $643,000
Q2 2024 Aug 14, 2024	SELL	$3.51 - $5.21 $207,139 - $307,462	-59,014 Reduced 31.21%	130,070 $565,000
Q1 2024 May 15, 2024	SELL	$4.86 - $6.39 $815,454 - $1.07 Million	-167,789 Reduced 47.02%	189,084 $949,000
Q4 2023 Feb 14, 2024	SELL	$4.7 - $6.63 $4.04 Million - $5.7 Million	-859,333 Reduced 70.66%	356,873 $2.24 Million
Q2 2023 Aug 14, 2023	SELL	$8.94 - $11.74 $3.91 Million - $5.14 Million	-437,807 Reduced 26.47%	1,216,206 $12.4 Million
Q1 2023 May 15, 2023	BUY	$5.59 - $9.47 $4.63 Million - $7.84 Million	828,288 Added 100.31%	1,654,013 $15 Million
Q4 2022 Feb 14, 2023	BUY	$4.02 - $7.53 $3.22 Million - $6.03 Million	800,408 Added 3161.54%	825,725 $5.92 Million
Q3 2022 Nov 14, 2022	SELL	$4.48 - $6.52 $48,827 - $71,061	-10,899 Reduced 30.09%	25,317 $165,000
Q2 2022 Aug 15, 2022	BUY	$4.3 - $6.48 $49,213 - $74,163	11,445 Added 46.2%	36,216 $175,000
Q1 2022 May 16, 2022	SELL	$3.9 - $6.11 $33,411 - $52,344	-8,567 Reduced 25.7%	24,771 $141,000
Q4 2021 Feb 14, 2022	SELL	$3.88 - $6.9 $791 - $1,407	-204 Reduced 0.61%	33,338 $167,000
Q3 2021 Nov 15, 2021	SELL	$4.93 - $7.15 $119,182 - $172,851	-24,175 Reduced 41.89%	33,542 $223,000
Q2 2021 Aug 16, 2021	BUY	$5.19 - $7.38 $299,551 - $425,951	57,717 New	57,717 $353,000
Q2 2020 Aug 14, 2020	SELL	$7.01 - $10.96 $245,763 - $384,246	-35,059 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$5.4 - $10.45 $189,318 - $366,366	35,059 New	35,059 $259,000
Q3 2019 Nov 14, 2019	SELL	$3.24 - $7.35 $109,447 - $248,283	-33,780 Closed	0 $0
Q2 2019 Aug 15, 2019	BUY	$2.48 - $3.76 $83,774 - $127,012	33,780 New	33,780 $108,000
Q3 2018 Nov 14, 2018	SELL	$4.22 - $6.03 $81,446 - $116,379	-19,300 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$5.53 - $15.4 $106,729 - $297,220	19,300 New	19,300 $109,000
Q1 2018 May 15, 2018	SELL	$11.62 - $17.32 $443,674 - $661,312	-38,182 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$11.8 - $17.31 $450,547 - $660,930	38,182	38,182 $462,000

Others Institutions Holding SCPH

# of Institutions

101

Shares Held

37M

Call Options Held

757K

Put Options Held

View Full List

About scPharmaceuticals Inc.

Ticker SCPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,402,100
Market Cap $132M
Description
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...

More about SCPH

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account